The Patent Finder

Viravaxx AG

Also on record
Records under this name other than the patents Viravaxx AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 2 of 2 · Back to Viravaxx AG

PatentTitleStatus Expires Confidence
US 11,237,166Method for detecting HIV-1-specific antibodies using clade C env polypeptides
Lapsed on the fee record
Ended Feb 1, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 1, 2026From the USPTO record
US 9,638,694Method for diagnosing a rhinovirus infection
Lapsed on the fee record
Ended May 2, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 2, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited